CORV - Correvio Pharma Corp. (CORV) CEO Mark Corrigan on Q2 2019 Results - Earnings Call Transcript
Correvio Pharma Corp. (CORV)
Q2 2019 Earnings Conference Call
August 14, 2019 08:30 AM ET
Company Participants
Justin Renz - CFO
Mark Corrigan - CEO
David Dean - Chief Business Development Officer
Conference Call Participants
David Martin - Bloom Burton
Swayampakula Ramakanth - H.C. Wainwright
Brock Aynsley - CIBC Wood Gundy
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to Correvio's Second Quarter 2019 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company’s request.
I would now like to